US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.6505
  • +0.0405+6.64%
Close Aug 8 16:00 ET
2.90MMarket Cap-474P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
135.14%1.74M
27.24%4.53M
84.85%1.21M
54.94%1.43M
79.64%1.14M
-44.88%739.29K
-14.07%3.56M
-23.85%655.78K
20.92%924.06K
-51.36%636.67K
Selling and administrative expenses
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
-16.61%422.69K
-59.24%476.16K
-General and administrative expense
-29.05%277.61K
-38.68%1.21M
-49.58%200.8K
-27.21%307.68K
-35.45%307.36K
-41.73%391.26K
-34.46%1.97M
-44.27%398.26K
-16.61%422.69K
-59.24%476.16K
Research and development costs
319.72%1.46M
108.90%3.32M
292.76%1.01M
124.19%1.12M
421.06%836.38K
-48.04%348.03K
39.80%1.59M
75.70%257.52K
94.87%501.37K
14.17%160.52K
Operating profit
-135.14%-1.74M
-27.24%-4.53M
-84.85%-1.21M
-54.94%-1.43M
-79.64%-1.14M
44.88%-739.29K
14.07%-3.56M
23.85%-655.78K
-20.92%-924.06K
51.36%-636.67K
Net non-operating interest income expense
-45.90%13.87K
224.40%156.79K
-32.52%40.81K
253.55%37.26K
881.20%53.1K
261.43%25.63K
110.42%48.33K
326.63%60.47K
109.23%10.54K
97.16%-6.8K
Non-operating interest income
-75.63%13.87K
42.35%264.48K
-41.95%53.66K
62.88%69.22K
157.47%84.71K
216.65%56.89K
459.49%185.79K
183.18%92.43K
12,547.62%42.5K
14,393.39%32.9K
Non-operating interest expense
--0
-21.66%107.68K
-59.78%12.85K
0.00%31.96K
-20.37%31.61K
-7.63%31.26K
-72.34%137.46K
-46.13%31.96K
-72.08%31.96K
-83.40%39.7K
Other net income (expense)
104.47%198
-1,268.74%-630.32K
-8,222.56%-504.76K
81.54%-2.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
-11.78K
-23.25K
Gain on sale of security
104.47%198
-1,268.74%-630.32K
-7,876.31%-483.76K
-96.66%-23.18K
-411.69%-118.95K
10.57%-4.43K
-156.72%-46.05K
-143.97%-6.07K
---11.78K
---23.25K
Other non- operating income (expenses)
----
----
----
--21K
----
----
----
----
----
----
Income before tax
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Net income continuous Operations
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Minority interest income
Net income attributable to the parent company
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Basic earnings per share
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
33.87%-0.82
30.00%-0.14
-5.00%-0.21
65.91%-0.15
Diluted earnings per share
-129.41%-0.39
-40.24%-1.15
-171.43%-0.38
-52.38%-0.32
-86.67%-0.28
46.88%-0.17
33.87%-0.82
30.00%-0.14
-5.00%-0.21
65.91%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 135.14%1.74M27.24%4.53M84.85%1.21M54.94%1.43M79.64%1.14M-44.88%739.29K-14.07%3.56M-23.85%655.78K20.92%924.06K-51.36%636.67K
Selling and administrative expenses -29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K-16.61%422.69K-59.24%476.16K
-General and administrative expense -29.05%277.61K-38.68%1.21M-49.58%200.8K-27.21%307.68K-35.45%307.36K-41.73%391.26K-34.46%1.97M-44.27%398.26K-16.61%422.69K-59.24%476.16K
Research and development costs 319.72%1.46M108.90%3.32M292.76%1.01M124.19%1.12M421.06%836.38K-48.04%348.03K39.80%1.59M75.70%257.52K94.87%501.37K14.17%160.52K
Operating profit -135.14%-1.74M-27.24%-4.53M-84.85%-1.21M-54.94%-1.43M-79.64%-1.14M44.88%-739.29K14.07%-3.56M23.85%-655.78K-20.92%-924.06K51.36%-636.67K
Net non-operating interest income expense -45.90%13.87K224.40%156.79K-32.52%40.81K253.55%37.26K881.20%53.1K261.43%25.63K110.42%48.33K326.63%60.47K109.23%10.54K97.16%-6.8K
Non-operating interest income -75.63%13.87K42.35%264.48K-41.95%53.66K62.88%69.22K157.47%84.71K216.65%56.89K459.49%185.79K183.18%92.43K12,547.62%42.5K14,393.39%32.9K
Non-operating interest expense --0-21.66%107.68K-59.78%12.85K0.00%31.96K-20.37%31.61K-7.63%31.26K-72.34%137.46K-46.13%31.96K-72.08%31.96K-83.40%39.7K
Other net income (expense) 104.47%198-1,268.74%-630.32K-8,222.56%-504.76K81.54%-2.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K-11.78K-23.25K
Gain on sale of security 104.47%198-1,268.74%-630.32K-7,876.31%-483.76K-96.66%-23.18K-411.69%-118.95K10.57%-4.43K-156.72%-46.05K-143.97%-6.07K---11.78K---23.25K
Other non- operating income (expenses) --------------21K------------------------
Income before tax -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Income tax 0000000000
Net income -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Net income continuous Operations -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Minority interest income
Net income attributable to the parent company -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Basic earnings per share -129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.1733.87%-0.8230.00%-0.14-5.00%-0.2165.91%-0.15
Diluted earnings per share -129.41%-0.39-40.24%-1.15-171.43%-0.38-52.38%-0.32-86.67%-0.2846.88%-0.1733.87%-0.8230.00%-0.14-5.00%-0.2165.91%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg